Arylsulfonamide compounds

US7173035B2 · kind B2 · utility

Assignee

• Biovitrum AB · SE

Inventors

• Ulf Bremberg · Upplands Väsby, SE
• Patrizia Caldirola · Uppsala, SE
• Annika Jensen · Uppsala, SE
• Gary Johansson · Hockessin, US
• Lori Sutin · Knivsta, SE
• Andrew Mott · Knivsta, SE
• Jan Tejbrant · Stuvsta-Snättringe, SE

Key dates

• Filing date: May 10, 2002
• Grant date: Feb 6, 2007
• Expiry date: Jun 10, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/08
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.